Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter L Collins

Showing results (151-160 of 247) with videos related to

Pageof 25
Sort By:
Journal of Virology|April 26, 2012
Complete genome sequences of Newcastle disease virus strains circulating in chicken populations of IndonesiaSa Xiao, Anandan Paldurai, Baibaswata Nayak, et al.
The Journal of Infectious Diseases|August 3, 2013
Experimental infection of adults with recombinant wild-type human metapneumovirusKawsar R Talaat, Ruth A Karron, Bhagvanji Thumar, et al.
Virology|September 11, 2012
Human parainfluenza virus serotypes differ in their kinetics of replication and cytokine secretion in human tracheobronchial airway epitheliumAnne Schaap-Nutt, Rachael Liesman, Emmalene J Bartlett, et al.
Journal of Virology|January 5, 2002
Mucosal immunization of rhesus monkeys against respiratory syncytial virus subgroups A and B and human parainfluenza virus type 3 by using a live cDNA-derived vaccine based on a host range-attenuated bovine parainfluenza virus type 3 vector backboneAlexander C Schmidt, Daniel R Wenzke, Josephine M McAuliffe, et al.
Virus Genes|April 4, 2002
Sequence analysis of the Washington/1964 strain of human parainfluenza virus type 1 (HPIV1) and recovery and characterization of wild-type recombinant HPIV1 produced by reverse geneticsJason T Newman, Sonja R Surman, Jeffrey M Riggs, et al.
The Journal of General Virology|June 17, 2005
Interaction between the respiratory syncytial virus G glycoprotein cytoplasmic domain and the matrix proteinReena Ghildyal, Dongsheng Li, Irene Peroulis, et al.
Journal of Virology|November 1, 2019
Optimization of the Codon Pair Usage of Human Respiratory Syncytial Virus Paradoxically Resulted in Reduced Viral Replication <i>In Vivo</i> and Reduced ImmunogenicityCyril Le Nouën, Cindy L Luongo, Lijuan Yang, et al.
Journal of Virology|March 3, 2017
Attenuated Human Parainfluenza Virus Type 1 Expressing Ebola Virus Glycoprotein GP Administered Intranasally Is Immunogenic in African Green MonkeysMatthias Lingemann, Xueqiao Liu, Sonja Surman, et al.
Vaccine|June 14, 2005
Human parainfluenza virus type I (HPIV1) vaccine candidates designed by reverse genetics are attenuated and efficacious in African green monkeysEmmalene J Bartlett, Emerito Amaro-Carambot, Sonja R Surman, et al.
Virology Journal|May 24, 2011
Mutation of the elongin C binding domain of human respiratory syncytial virus non-structural protein 1 (NS1) results in degradation of NS1 and attenuation of the virusClaire P Straub, Wei-Har Lau, Faith M Preston, et al.
Pageof 25

Showing results (151-160 of 247) with videos related to

Sort By:
Pageof 25
Journal of Virology|April 26, 2012
Complete genome sequences of Newcastle disease virus strains circulating in chicken populations of IndonesiaSa Xiao, Anandan Paldurai, Baibaswata Nayak, et al.
The Journal of Infectious Diseases|August 3, 2013
Experimental infection of adults with recombinant wild-type human metapneumovirusKawsar R Talaat, Ruth A Karron, Bhagvanji Thumar, et al.
Virology|September 11, 2012
Human parainfluenza virus serotypes differ in their kinetics of replication and cytokine secretion in human tracheobronchial airway epitheliumAnne Schaap-Nutt, Rachael Liesman, Emmalene J Bartlett, et al.
Journal of Virology|January 5, 2002
Mucosal immunization of rhesus monkeys against respiratory syncytial virus subgroups A and B and human parainfluenza virus type 3 by using a live cDNA-derived vaccine based on a host range-attenuated bovine parainfluenza virus type 3 vector backboneAlexander C Schmidt, Daniel R Wenzke, Josephine M McAuliffe, et al.
Virus Genes|April 4, 2002
Sequence analysis of the Washington/1964 strain of human parainfluenza virus type 1 (HPIV1) and recovery and characterization of wild-type recombinant HPIV1 produced by reverse geneticsJason T Newman, Sonja R Surman, Jeffrey M Riggs, et al.
The Journal of General Virology|June 17, 2005
Interaction between the respiratory syncytial virus G glycoprotein cytoplasmic domain and the matrix proteinReena Ghildyal, Dongsheng Li, Irene Peroulis, et al.
Journal of Virology|November 1, 2019
Optimization of the Codon Pair Usage of Human Respiratory Syncytial Virus Paradoxically Resulted in Reduced Viral Replication <i>In Vivo</i> and Reduced ImmunogenicityCyril Le Nouën, Cindy L Luongo, Lijuan Yang, et al.
Journal of Virology|March 3, 2017
Attenuated Human Parainfluenza Virus Type 1 Expressing Ebola Virus Glycoprotein GP Administered Intranasally Is Immunogenic in African Green MonkeysMatthias Lingemann, Xueqiao Liu, Sonja Surman, et al.
Vaccine|June 14, 2005
Human parainfluenza virus type I (HPIV1) vaccine candidates designed by reverse genetics are attenuated and efficacious in African green monkeysEmmalene J Bartlett, Emerito Amaro-Carambot, Sonja R Surman, et al.
Virology Journal|May 24, 2011
Mutation of the elongin C binding domain of human respiratory syncytial virus non-structural protein 1 (NS1) results in degradation of NS1 and attenuation of the virusClaire P Straub, Wei-Har Lau, Faith M Preston, et al.
Pageof 25